healthtech Value proposition
Leaders in digital assessment
Cambridge Cognition Plc (AIM: COG) is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. Our software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.
Our digital health products have been used for over 30 years in thousands of academic and industry clinical trials by the world's leading pharmaceutical and biotech companies, academic institutions and health organisations.
cognitive assessments, dementia, CANTAB, mental health, digital health, technology, software, Alzheimer's disease, brain health, and cognition
Homepage - Cambridge Cognition
Backed by over 30 years of scientific discovery and validation, Cambridge Cognition offers the end-to-end platform for CNS clinical trials.
https://cambridgecognition.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Roche Pharmaceutical, Biotechnology, Biotechnology Research | Roche Pharmaceutical, Biotechnology, Biotechnology Research | Other 23 Oct 2023 | | |
 Biogen Biotechnology, Biotechnology Research | Biogen Biotechnology, Biotechnology Research | Other 23 Oct 2023 | | |
 AbbVie Pharmaceutical, Pharmaceutical Manufacturing | AbbVie Pharmaceutical, Pharmaceutical Manufacturing | Other 23 Oct 2023 | | |